Preclinical trials of human erythrocyte superoxide dismutase injection.
To assess the quality of human erythrocyte superoxide dismutase (SOD) injection reaching the official standard for its clinical uses. Human erythrocyte SOD injection prepared by McCord-Fridovich's method without column chromatography but with some modifications was used in preclinical trials, to observe the general pharmacology and pharmacodynamics of the product. The quality of human erythrocyte SOD injection conformed to the official standard of a biological product, which was found to be non-toxic and did not have any effects on the central and autonomic nervous systems as well as cardiovascular and respiratory systems. The efficacy of anti-inflammation and promotion of immuno-regulation especially on carrageenan and adjuvant-induced polyarthritis were shown in animals. Human erythrocyte SOD injection is appropriate for prophylactic and therapeutic uses in clinical trials.